Spain vs Sri Lanka: Cause of death, by non-communicable diseases, ages 0-4, male
Spain
43.2%
in 2021
Sri Lanka
41.7%
in 2021
Spain rank
32nd
Sri Lanka rank
35th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Spain
- Sri Lanka
How they compare
Spain currently reports 43.2% against 41.7% in Sri Lanka, a difference of 1.5%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Spain ahead.
Spain ranks 32nd and Sri Lanka ranks 35th of 185 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Spain | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.0% | 34.8% | 12.2% | Spain |
| 2010s | 43.2% | 40.6% | 2.6% | Spain |
| 2020s | 43.8% | 42.1% | 1.6% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Spain or Sri Lanka?
- Spain, at 43.2% against 41.7% in Sri Lanka as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Spain and Sri Lanka?
- 1.5%, with Spain ahead.
- How many years of comparable data are there for Spain and Sri Lanka?
- 6 years are reported by both, from 2000 to 2021.
- How do Spain and Sri Lanka rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Spain ranks 32nd and Sri Lanka ranks 35th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.